Company

Pandorum Technologies

Programmable regenerative medicine developer

Healthcare & Life SciencesBengaluruFounded 2011

Pandorum Technologies key numbers

$41.60MValuation · 2021Source: Pandorum raises $18m Series B for exosome therapy $50.59M+Total raised · 2026Source: Pandorum raises $18m Series B for exosome therapy

As reported on the date of each story; tap a number for its source.

Stories cover its funding news. Sectors: Healthcare & Life Sciences. Stages: Series B. Based in Bengaluru.

The founders

Tuhin Bhowmick

CEO

Founded in 2011.
Leads the strategic direction of the regenerative medicine platform.

Arun Chandru

Co-founder

Co-founded Pandorum Technologies in 2011.

Who put in money

Ashish KacholiaAvinya FundBurman FamilyGalentic PharmaNoblevast AdvisoryProtons Corporate

Every story on Pandorum Technologies

PTPandorum Technologies · Funding · 9 February 2026 · $18MPandorum raises $18m Series B for exosome therapyPandorum develops programmable regenerative medicine using tunable exosome-based therapies to reprogram damaged tissue

For Pandorum Technologies: add the “Featured on StopDown” badge

Put this on your website's press or media page. It links readers to Pandorum Technologies on StopDown.

Light

<a href="https://stopdown.in/company/pandorum" target="_blank" title="Pandorum Technologies on StopDown"><img src="https://stopdown.in/badge/featured-light@2x.png" alt="Featured on StopDown" width="232" height="56" style="border:0"></a>

Dark

<a href="https://stopdown.in/company/pandorum" target="_blank" title="Pandorum Technologies on StopDown"><img src="https://stopdown.in/badge/featured-dark@2x.png" alt="Featured on StopDown" width="232" height="56" style="border:0"></a>

· About the badge

#Pandorum Technologies key numbers

●The founders